Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Mucosal Cytotoxic T Lymphocyte Responses

  • Read more about Mucosal Cytotoxic T Lymphocyte Responses
US Application 60/261,083
Filed on 2001-01-10

Telomerase Immortalized Fibroblast Cell Lines

  • Read more about Telomerase Immortalized Fibroblast Cell Lines
US Application 60/260,625
Filed on 2001-01-09

Identification of New Small RNAs and ORFs

  • Read more about Identification of New Small RNAs and ORFs
US Application 60/266,402
Filed on 2001-02-01

Use of Lipoxygenase Inhibitors And PPar Ligands as Anti-Cancer Therapeutic And Intervention Agents

  • Read more about Use of Lipoxygenase Inhibitors And PPar Ligands as Anti-Cancer Therapeutic And Intervention Agents
US Application 60/302,155
Filed on 2001-06-29

Parallel Measurements of Multiple RNA, Proteins And Antibody Binding Using CryoArray

  • Read more about Parallel Measurements of Multiple RNA, Proteins And Antibody Binding Using CryoArray
US Application 60/316,544
Filed on 2001-08-31

Transforming Growth Factor Beta(TGF-BETA) Antagonist Selectively Neutralize PATHOLOGICAL TGF BETA.

  • Read more about Transforming Growth Factor Beta(TGF-BETA) Antagonist Selectively Neutralize PATHOLOGICAL TGF BETA.
US Application 60/300,087
Filed on 2001-06-21

Human UGRP (Uteroglobin-Related Protein) 1 Promoter And its Use

  • Read more about Human UGRP (Uteroglobin-Related Protein) 1 Promoter And its Use
US Application 60/299,828
Filed on 2001-06-20

PRAC and PRAC-Y, Smalll Nuclear Proteins Found in Prostate and Colon Cancer, and Uses Thereof

  • Read more about PRAC and PRAC-Y, Smalll Nuclear Proteins Found in Prostate and Colon Cancer, and Uses Thereof
US Application 60/282,704
Filed on 2001-04-09

Aerosolized Retinoids For The Treatment of Lung Cancer

  • Read more about Aerosolized Retinoids For The Treatment of Lung Cancer
US Application 60/187,539
Filed on 2000-03-07

Novel TRP2 Isoform Containing HLA-A2 Restricted Cytotoxic T Lymphocyte Epitopes

  • Read more about Novel TRP2 Isoform Containing HLA-A2 Restricted Cytotoxic T Lymphocyte Epitopes
US Application 60/277,108
Filed on 2001-03-19

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 191
  • Page 192
  • Page 193
  • Page 194
  • Page 195
  • Page 196
  • Page 197
  • Page 198
  • Page 199
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health